The Latest in Endocrinology

Internal Medicine News

Evidence links common endocrine-disrupting chemicals to obesity, diabetes, reproductive disorders

September 28, 2015

Internal Medicine News

ICAAC: 2015 brings three major systematic reviews of diabetic foot infection therapy

September 26, 2015

Internal Medicine News

Long-acting insulin degludec – and degludec combo drug – win FDA nod

September 26, 2015

Internal Medicine News

EASD: SGLT2 inhibitors show potential in 1DM despite DKA concern

September 25, 2015

Internal Medicine News

AACE releases new position statement on testosterone replacement therapy in men

September 25, 2015

Internal Medicine News

Recall issued on U.S. Compounding sterile products

September 24, 2015

Internal Medicine News

In type 2 diabetes, pump therapy costs more but saves much

September 24, 2015

Internal Medicine News

Empagliflozin’s triumph respins FDA’s diabetes drug mandate

September 21, 2015

Internal Medicine News

Diabetic foot ulcer: Early closure post debridement best

September 21, 2015

Internal Medicine News

‘Artificial beta-cell’ insulin systems post more positive data

September 18, 2015

Internal Medicine News

EASD: SGLT2 inhibitor empagliflozin cuts CV risk in patients with type 2 diabetes

September 18, 2015

Internal Medicine News

When stepping up type 2 treatment, GLP-1 agonists have the edge

September 17, 2015

Internal Medicine News

No difference in long-term cost for diabetes treatment with bariatric surgery

September 17, 2015

Internal Medicine News

Liraglutide/metformin targets glycemic goal in type 2 diabetes

September 16, 2015

Internal Medicine News

Long-acting basal insulin controls HbA1c as well as glargine

September 16, 2015